Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Mark S. Miller | M | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Susan M. Elliott | F | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Joseph Sardano | M | 71 |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | 6 anni |
Charles N. Ellis | M | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Teresa Bair | F | 53 |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 5 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Ryan V. Hartwell
- Contatti personali